HUM * Stock Overview
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Humana Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5,433.00 |
| 52 Week High | US$9,435.20 |
| 52 Week Low | US$4,990.00 |
| Beta | 0.46 |
| 1 Month Change | 5.50% |
| 3 Month Change | -15.27% |
| 1 Year Change | -42.83% |
| 3 Year Change | -40.99% |
| 5 Year Change | 19.26% |
| Change since IPO | -9.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| HUM * | MX Healthcare | MX Market | |
|---|---|---|---|
| 7D | 2.2% | 2.7% | -0.8% |
| 1Y | -42.8% | 2.8% | 2.4% |
Return vs Industry: HUM * underperformed the MX Healthcare industry which returned 0.9% over the past year.
Return vs Market: HUM * underperformed the MX Market which returned 1.8% over the past year.
Price Volatility
| HUM * volatility | |
|---|---|
| HUM * Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.1% |
| 10% least volatile stocks in MX Market | 2.0% |
Stable Share Price: HUM * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HUM *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 67,600 | Bruce Broussard | www.humana.com |
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals.
Humana Inc. Fundamentals Summary
| HUM * fundamental statistics | |
|---|---|
| Market cap | Mex$655.49b |
| Earnings (TTM) | Mex$33.79b |
| Revenue (TTM) | Mex$1.85t |
19.4x
P/E Ratio0.4x
P/S RatioIs HUM * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HUM * income statement (TTM) | |
|---|---|
| Revenue | US$109.24b |
| Cost of Revenue | US$91.66b |
| Gross Profit | US$17.58b |
| Other Expenses | US$15.59b |
| Earnings | US$1.99b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 01, 2024
| Earnings per share (EPS) | 16.52 |
| Gross Margin | 16.10% |
| Net Profit Margin | 1.82% |
| Debt/Equity Ratio | 83.7% |
How did HUM * perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield22%
Payout RatioDoes HUM * pay a reliable dividends?
See HUM * dividend history and benchmarks| Humana dividend dates | |
|---|---|
| Ex Dividend Date | Jun 28 2024 |
| Dividend Pay Date | Jul 26 2024 |
| Days until Ex dividend | 54 days |
| Days until Dividend pay date | 82 days |
Does HUM * pay a reliable dividends?
See HUM * dividend history and benchmarks